The molecular selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from molecular dynamics simulation

Polycomb CBX proteins regulate gene expression by targeting Polycomb repressive complex 1 (PRC1) to sites of H3K27me3 via their chromodomains, which plays a key role in the development of numerous cancers. UNC3866, is a recently reported peptide-based inhibitor of the methyllysine (Kme) reading function of CBX chromodomains (CBX2, 4 and 6-8). The previous experiments showed that UNC3866 bound the chromodomains of CBX7 strongly, with ∼20-fold selectivity over other CBX chromodomains. However, the potential mechanism of UNC3866 preferentially binding to CBX7 is still unknown. In this study, we performed two pairs of microsecond molecular dynamic simulations (CBX2 (-UNC3866)) and (CBX7 (-UNC3866)) to study the inhibition and isoform-selective mechanism of UNC3866 to CBX7. The conformational analysis of apo- and holo- CBX2 and CBX7 indicated that the aromatic cage of CBX7 protein was more prone to be induced by UNC3866 relative to CBX2 protein. The results of predicted binding free energy suggested the binding affinity of UNC3866 with CBX7 was stronger than that with CBX2, because of the lower binding free energy of the former. Furthermore, the energetic origin of UNC3866 selective for CBX7 protein mainly came from the higher van der Waals contributions. The binding mode analysis showed that Asn47 of CBX2 formed a hydrogen bond with the OH group of C-terminal cap of UNC3866, inducing the conformational changes of diethyllysine of UNC3866 that is obviously different from that in CBX7. Additionally, His39 in CBX2 chromodomain interrupted the structured aromatic cage, partly explaining the reason for UNC3866 preferring for binding to CBX7. The proposal of this selective mechanism could be helpful for the rational design of novel selective inhibitors of the Polycomb CBX protein.

[1]  I. Paci,et al.  Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family. , 2016, ACS medicinal chemistry letters.

[2]  S. Genheden,et al.  The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities , 2015, Expert opinion on drug discovery.

[3]  J. Wulff,et al.  Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7). , 2014, Journal of medicinal chemistry.

[4]  W. Sippl,et al.  Mind the Methyl: Methyllysine Binding Proteins in Epigenetic Regulation , 2014, ChemMedChem.

[5]  C. Allis,et al.  Specificity of the Chromodomain Y Chromosome Family of Chromodomains for Lysine-methylated ARK(S/T) Motifs* , 2008, Journal of Biological Chemistry.

[6]  S. Frye,et al.  Chemical probes for methyl lysine reader domains. , 2016, Current opinion in chemical biology.

[7]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[8]  Nancy Cheng,et al.  A cellular chemical probe targeting the chromodomains of Polycomb Repressive Complex 1 , 2015, Nature chemical biology.

[9]  J. Min,et al.  Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. , 2003, Genes & development.

[10]  R. Dror,et al.  Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.

[11]  Rong-gang Ma,et al.  Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins , 2014, Journal of Zhejiang University SCIENCE B.

[12]  S. Frye,et al.  Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3. , 2013, Journal of medicinal chemistry.

[13]  M. Mezei,et al.  Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7. , 2016, ACS medicinal chemistry letters.

[14]  Antje Wolf,et al.  Principal component and clustering analysis on molecular dynamics data of the ribosomal L11·23S subdomain , 2012, Journal of Molecular Modeling.

[15]  W. Lam,et al.  Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role , 2014, British Journal of Cancer.

[16]  V. Stojanoff,et al.  Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain. , 2015, Chemistry & biology.

[17]  Shili Duan,et al.  Recognition and Specificity Determinants of the Human Cbx Chromodomains* , 2010, The Journal of Biological Chemistry.

[18]  Ju-Guang Han,et al.  Exploring interaction mechanisms of the inhibitor binding to the VP35 IID region of Ebola virus by all atom molecular dynamics simulation method , 2015, Proteins.

[19]  J. Ji,et al.  Polycomb CBX7 Directly Controls Trimethylation of Histone H3 at Lysine 9 at the p16 Locus , 2010, PloS one.

[20]  Jianyin Shao,et al.  Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms. , 2007, Journal of chemical theory and computation.

[21]  S. Frye,et al.  Structure–activity relationships of methyl-lysine reader antagonists , 2012 .

[22]  Tuning the smooth particle mesh Ewald sum: application on ionic solutions and dipolar fluids. , 2014, The Journal of chemical physics.

[23]  Y. Sang,et al.  Chromobox Homolog 4 Is Correlated with Prognosis and Tumor Cell Growth in Hepatocellular Carcinoma , 2013, Annals of Surgical Oncology.

[24]  S. Frye,et al.  Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains. , 2016, Journal of medicinal chemistry.

[25]  T. Kerppola,et al.  Changes in the Distributions and Dynamics of Polycomb Repressive Complexes during Embryonic Stem Cell Differentiation , 2008, Molecular and Cellular Biology.

[26]  K. Helin,et al.  Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation , 2013, Nature Cell Biology.

[27]  D. Beach,et al.  Polycomb CBX7 has a unifying role in cellular lifespan , 2004, Nature Cell Biology.

[28]  C. Bountra,et al.  Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.

[29]  A. Fusco,et al.  CBX7 is a tumor suppressor in mice and humans , 2012 .

[30]  Ross C. Walker,et al.  An overview of the Amber biomolecular simulation package , 2013 .

[31]  Toshima Z. Parris,et al.  Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma , 2014, BMC Cancer.

[32]  S. Frye,et al.  Chromodomain Ligand Optimization via Target-Class Directed Combinatorial Repurposing. , 2016, ACS chemical biology.

[33]  Yunxiang Mu,et al.  Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1. , 2015, ACS chemical biology.

[34]  P. Angrand,et al.  Interaction Proteomics Analysis of Polycomb Proteins Defines Distinct PRC1 Complexes in Mammalian Cells* , 2011, Molecular & Cellular Proteomics.

[35]  S. Lowe,et al.  Role of the chromobox protein CBX7 in lymphomagenesis , 2007, Proceedings of the National Academy of Sciences.

[36]  Leizhen Zheng,et al.  Oncogenic role of the chromobox protein CBX7 in gastric cancer , 2010, Journal of experimental & clinical cancer research : CR.

[37]  Charles A Laughton,et al.  Van der Waals interactions dominate ligand-protein association in a protein binding site occluded from solvent water. , 2005, Journal of the American Chemical Society.

[38]  Pin-Chih Su,et al.  Comparison of radii sets, entropy, QM methods, and sampling on MM‐PBSA, MM‐GBSA, and QM/MM‐GBSA ligand binding energies of F. tularensis enoyl‐ACP reductase (FabI) , 2015, J. Comput. Chem..

[39]  A. H. Smits,et al.  Cdyl, a New Partner of the Inactive X Chromosome and Potential Reader of H3K27me3 and H3K9me2 , 2013, Molecular and Cellular Biology.

[40]  Bing Li,et al.  Readers of histone modifications , 2011, Cell Research.

[41]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[42]  J. C. Eissenberg Structural biology of the chromodomain: form and function. , 2012, Gene.

[43]  K. Sharp,et al.  Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models , 1994 .